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Abstract
We summarize all original research in the field of respiratory
intensive care medicine published in 2005 in Critical Care.
Twenty-seven articles were grouped into the following categories
and subcategories to facilitate rapid overview: mechanical
ventilation (physiology, spontaneous breathing during mechanical
ventilation, high frequency oscillatory ventilation, side effects of
mechanical ventilation, sedation, and prone positioning); infection
(pneumonia and sepsis); monitoring (ventilatory monitoring,
pulmonary artery catheter and pulse oxymeter); and education
(training and health outcome).
Introduction
This article summarizes the original research in the field of
respirology that was published in 2005 in Critical Care. We
grouped the articles into subcategories to help the reader get




In acute respiratory distress syndrome (ARDS) the amount of
aerated lung is markedly reduced as a result of alveolar
collapse and flooding. Rylander and coworkers [1] assessed
the volume of poorly or nonventilated gas in mechanically
ventilated ARDS patients. They assumed that the difference
ratio between ventilated gas volume (end-expiratory lung
volume, measured using sulphur hexafluoride) and total gas
volume (total end-expiratory gas volume independent of
ventilation, measured using computed tomography) represents
poorly or nonventilated gas volume. About one-third of the total
gas volume was poorly or nonventilated in the lungs of ARDS
patients at a positive end-expiratory pressure (PEEP) level of
5 cmH2O. This uneven distribution of ventilation is probably
due to the presence of small airway closure and/or obstruction,
and a recruitment procedure might ameliorate this.
To detect recruitment, Henzler and coworkers [2] compared
commonly used measures of lung mechanics for improve-
ment in oxygenation. In an easily recruitable model of acute
lung injury (ALI), recruitment (45 cmH2O for 40 s) did not
result in oxygenation changes consistent with recruitment.
However, changes in aerated and nonaerated lung after the
recruitment manoeuvre were adequately represented by
changes in plateau pressure, respiratory system compliance
and recruitable volume. It seems that the degree of improve-
ment in oxygenation is not so much determined by reduction
in nonaerated lung as by the blood flow through these regions.
Extracorporeal membrane oxygenation (ECMO) provides
temporary extracorporeal life support for children with severe
respiratory or cardiac failure. ECMO therapy is discontinued
when adequate pulmonary and/or cardiac function returns.
As oxygenation improves, tidal volume increases and chest
radiographs reveal a reduction in pulmonary opacification.
Hermon and coworkers [3] investigated whether surfactant
application could influence these variables in children with
respiratory failure. After application of surfactant, mean tidal
volume almost doubled (186% of baseline value), mean
compliance increased significantly (176% of baseline value)
and radiographic scores tended to decrease within 48 hours.
Surfactant treatment did not affect mortality but it helped in
weaning from ECMO.
Spontaneous breathing during mechanical ventilation
Wrigge and colleagues [4] demonstrated that spontaneous
breathing with airway pressure release ventilation promotes
Review
Year in review 2005: Critical Care — Respirology: mechanical
ventilation, infection, monitoring, and education
Jack J Haitsma1, Jesús Villar1,2 and Arthur S Slutsky1
1Interdepartmental Division of Critical Care, University of Toronto, Toronto, Canada
2Canarian Institute for Biomedical Research, Canary Islands, Spain
Corresponding author: Arthur S Slutsky, arthur.slutsky@utoronto.ca
Published: 29 June 2006 Critical Care 2006, 10:217 (doi:10.1186/cc4959)
This article is online at http://ccforum.com/content/10/3/217
© 2006 BioMed Central Ltd
ALI = acute lung injury; ARDS = acute respiratory distress syndrome; CMV = conventional mechanical ventilation; COPD = chronic obstructive pul-
monary disease; ECMO = extracorporeal membrane oxygenation; ET = endothelin; HFOV = high-frequency oscillatory ventilation; IAP = intra-
abdominal pressure; ICU = intensive care unit; IPAH = idiopathic pulmonary arterial hypertension; IPV = intrapulmonary percussive ventilation; PCP =
pulmonary capillary pressure; PEEP = positive end-expiratory pressure; SARS = severe acute respiratory syndrome; VAT = ventilator-associated
tracheobronchitis.Page 2 of 5
(page number not for citation purposes)
Critical Care    Vol 10 No 3 Haitsma et al.
alveolar recruitment mainly in dependent, juxtadiaphragmatic
lung regions, resulting in end-expiratory aeration. It also led to
a redistribution of tidal ventilation to dependent lung zones in
oleic acid induced lung injury. Spontaneous breathing with
airway pressure release ventilation countered the undesirable
cyclic alveolar collapse in dependent lung regions, which can
contribute to ventilator-associated lung injury, but no indices
of lung injury were assessed. These data are in support of the
hypothesis that active contractions of the diaphragm are a
major explanatory factor in the improved oxygenation
observed in animal models and in patients with ALI with
reduction in intrapulmonary shunt. These data suggest that
allowing spontaneous breathing activity in ALI could help to
reduce lung injury.
Haberthür and Guttmann [5] repeatedly applied a pattern of
different levels of PEEP in a heterogeneous population of
tracheally intubated patients during unsupported spontaneous
breathing. The level of PEEP significantly influenced resting
short-term breathing patterns by selectively affecting the
duration of expiration. A reduction in PEEP was paralleled by
an increase in respiratory rate and in minute ventilation, and –
paradoxically – tidal volume and inspiratory time were not
significantly affected. These data suggest the existence of the
Hering-Breuer inflation/deflation reflex in adults under
standard clinical conditions; this reflex, produced by
increased stretch receptor activity, leads to a prolongation of
expiration.
High-frequency oscillatory ventilation
Bollen and coworkers [6] reported the results of a multi-
centre, multinational trial of the safety and efficacy of high-
frequency oscillatory ventilation (HFOV) in ARDS patients.
The study was prematurely stopped because of poor patient
accrual and the completion of a similar trial. Thirty-seven
patients received HFOV and 24 patients received conven-
tional mechanical ventilation (CMV). There were no
statistically significant differences in mortality or survival
without supplemental oxygen. The authors suggested that
future trials should incorporate the oxygenation index (given
by [fractional inspired oxygen × mean airway pressure ×
100]/arterial carbon dioxide tension) for more informative
analysis, because a post hoc analysis suggested that there
was a relative improvement with HFOV compared with CMV
in patients with a higher baseline oxygenation index.
Slee-Wijffels and colleagues [7], in a retrospective single
centre study, reported on the use of HFOV in paediatric
patients (n = 53) who deteriorated on CMV. They observed
that HFOV rescue therapy was associated with a high overall
survival (64%). In patients with diffuse alveolar disease
(n = 32) the survival rate was 56%, and this rate was 88% in
patients with small airway disease (n = 17). Future studies
are necessary to evaluate whether the outcome in patients
with diffuse alveolar disease may be improved if HFOV is
applied earlier in the course of the lung disease.
Intrapulmonary percussive ventilation (IPV), a high-frequency
ventilation technique that is intended for therapeutic
mobilization of bronchial secretions, has primarily been used
in patients with cystic fibrosis in a stable state. However, it
has shown promise for increasing sputum production in
patients with chronic obstructive pulmonary disease (COPD).
Vargas and coworkers [8], in a randomized trial conducted in
patients with exacerbation of COPD, demonstrated that 30
min of IPV led to a significant decrease in respiratory rate, an
increase in arterial oxygen tension and a decrease in arterial
carbon dioxide tension (P < 0.05). No worsening of
exacerbation was observed in patients treated with IPV, as
compared with deterioration in six out of 17 patients in the
control group (P < 0.05). The hospital stay was also
significantly shorter in the IPV group than in the control group
(6.8 ± 1.0 days versus 7.9 ± 1.3 days; P < 0.05).
Side effects of mechanical ventilation
Pneumothorax often complicates the management of patients
with severe acute respiratory syndrome (SARS) who are
ventilated. Kao and coworkers [9] concluded that SARS
patients who suffered pneumothorax (12% of patients) were
more tachypnoeic on admission, and had more pronounced
hypoxaemia and hypercapnia during hospitalization, although
there were no significant differences in pressure, volume, or
mortality rate between patients with and those without
pneumothorax.
Critically ill patients frequently develop anaemia during their
intensive care unit (ICU) stay, which has partly been attributed
to a blunted erythropoietin response [10]. Erythropoietin is an
endogenous glycoprotein hormone that is the primary
stimulus for erythropoiesis. DeAngelo and colleagues [10]
demonstrated that the erythropoietin response is also blunted
in anaemic (haemoglobin 10.6 g/dl) mechanically ventilated
patients compared with matched anaemic ambulatory patients.
Sedation
Breen and coworkers [11] reported a randomized, open-
label, multicentre study comparing the safety and efficacy of
an analgesia-based sedation regimen using remifentanil
(n = 57) with those of a midazolam-based sedation regimen
with fentanyl or morphine added as analgesia (n = 48) in
critically ill patients requiring prolonged mechanical ventilation
for up to 10 days. The remifentanil-based sedation regimen
reduced the duration of mechanical ventilation by 53.5 hours
(P = 0.033) and reduced the time from the start of the
weaning process to extubation by 26.6 hours (P < 0.001).
Prone positioning
Prone positioning has been shown to improve arterial
oxygenation in about two-thirds of patients with ARDS;
however, it also increases intra-abdominal pressure (IAP).
The increased IAP does not severely impair cardiopulmonary,
renal, or hepatosplanchnic functions during short periods of
prone positioning. However, many patients included inPage 3 of 5
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previous studies were placed on air-cushioned beds, which
might have had an impact on these variables. In a prospective
randomized crossover study, Michelet and coworkers [12,13]
compared prone positioning on an air-cushioned bed with
that on a conventional foam mattress. Although IAP was
significantly higher and liver function decreased on the
conventional mattress, these effects were not associated with
differences in oxygenation or cardiovascular parameters.
Infection
Pneumonia
Mortensen and colleagues [14] investigated the impact of the
empiric use of β-lactams and fluorquinolones in severe
pneumonia. The use of only β-lactams has been reported to
be associated with increased mortality, whereas the combina-
tion with macrolides improved outcome. In a retrospective
analysis of 172 eligible patients (community-acquired
pneumonia) over a 3-year period, Mortensen and colleagues
[14] observed a 30-day mortality of 30% in patients treated
with β-lactams and fluorquinolone (n = 50) as compared with
a rate of 17.2% in patients treated with other guideline-
concordant antibiotics (n = 87). After adjusting for confoun-
ders, the use of β-lactam and fluoroquinolone was associated
with increased mortality (odds ratio 2.71).
In patients with cystic fibrosis aerosolized colistin has
successfully been used to treat acute pulmonary exacer-
bations of infection or initial colonization with Pseudomonas
aeruginosa  strains. Michalapoulos and coworkers [15]
retrospectively identified eight patients with nosocomial
pneumonia who received aerosolized colistin. Survival and
clinical cure rates for the infection were better in patients with
pneumonia who received additional aerosolized colistin,
although these findings were not statistically significantly
different from those in patients who received only intravenous
colistin treatment (survival 7/8 patients [87.5%] versus 34/45
patients [75.6%], P = 0.41; clinical cure: 7/8 patients
[87.5%] versus 30/45 patients [66.7%], P = 0.67). The
number of patients included was very small, but this retro-
spective study suggests that there is a need for a randomized
controlled trial examining the efficacy and safety of
aerosolized colistin for the management of patients with
nosocomial pneumonia.
Grigoriu and colleagues [16] conducted a prospective study
in mechanically ventilated patients and demonstrated that
cytological lesions of alveolar damage, expressed as the
presence of haemorrhage and desquamated type II pneumo-
cytes in bronchoalveolar lavage fluid, can be found in patients
with severe hospital-acquired or community-acquired
pneumonia. However, the poor sensitivity and the necessity
for a trained pathologist limits the potential utility of this
approach for day-to-day practice.
Ventilator-associated tracheobronchitis (VAT) is a common
nosocomial infection among mechanically ventilated patients,
with incidence rates reported in the literature of 3.7–10.6%.
Investigating the outcome of VAT in a retrospective,
observational, matched study design in patients without
chronic respiratory failure, Nseir and colleagues [17] found
that both duration of mechanical ventilation and ICU stay
were prolonged in these patients, although there was no
difference in mortality. Although all patients with VAT were
treated with antibiotics and treated for a longer period than
matched control individuals, most were not treated
specifically for VAT. Analysis of adequacy of antibiotic
treatment failed to show any difference, although this result is
limited by the small number of patients receiving adequate
treatment.
Garnacho-Montero and coworkers [18] assessed risk factors,
clinical features, management and outcomes in critically ill
patients in whom Aspergillus spp. were isolated from
respiratory secretions, using a database of 1756 patients
from a study designed to assess fungal infections. Treatment
with steroids (odds ratio 4.5), COPD (odds ratio 2.9) and
neutropenia (odds ratio 9.4) were significantly associated
with Aspergillus spp. isolation. Aspergillus spp. was recovered
in 36 patients; in 14 patients isolation of Aspergillus spp. was
interpreted as colonization (mortality 50%), in 20 patients it
was interpreted as invasive aspergillosis (mortality 80%), and
two cases were not classified. Antifungal treatment should be
considered in patients with clinical features of pneumonia,
with isolation of Aspergillus spp. from respiratory secretions,
and who have either COPD or are undergoing treatment with
corticosteroids. In contrast, antifungal treatment should not
be initiated when Aspergillus  spp. are recovered from
bronchial aspirates of critically ill patients without
predisposing risk factors and in the absence of clinical and
radiological signs of pneumonia. In these cases, isolation of
Aspergillus spp. should be interpreted as colonization.
Sepsis
In sepsis and ARDS a cascade of inflammatory responses
leads to production of proinflammatory cytokines. This
cascade might be inhibited by eliminating the pathogenic
toxins using haemoperfusion with a polymyxin B immobilized
fibre column. In a prospective uncontrolled observational
study, Kushi and coworkers [19] used this technique in 36
patients with ARDS caused by sepsis. Haemoperfusion
reduced levels of plasminogen activator inhibitor-1, neutrophil
elastase and interleukin-8 in blood at 48 hours, and improved
arterial oxygen tension/fractional inspired oxygen ratio at 96
hours after the start of treatment.
During sepsis, endothelin (ET)-1 is released into the blood-
stream by endothelial cells causing local vasoconstriction,
especially in the pulmonary circulation. Blocking the ET-1
receptor decreases the extravascular lung water index during
endotoxaemia [20]. Kuklin and coworkers [20] reported a
possible mechanism for explaining how a nonselective ET-1
receptor blocker (tezosentan) reduces translocation of the α-
Available online http://ccforum.com/content/10/3/217isoform of protein kinase C from the cytosol to the membrane
during endotoxaemia. In similar experiments, conducted in an
experimental animal model in which pulmonary oedema
develops following sepsis caused by caecal ligation and
puncture, Kuklin and coworkers [21] reduced pulmonary
oedema by blocking the ET-1 receptor. These experiments
suggest a possible way to reduce lung injury during sepsis.
Monitoring
Ventilatory monitoring
Frank and coworkers [22] used the Dräger Oxylog 3000TM
(Dräger Medical, Best, The Netherlands) to demonstrate that
oscillatory flow with potentially harmful effects may occur
during ventilation, especially in conditions with high
resistance such as occur in children with narrowed airways
(endotracheal tube internal diameter <6 mm) or severe
obstructive lung disease or airway diseases in adult patients.
If oscillations are present, then the ventilator setting must be
adjusted by reducing the steepness of the ramp in biphasic
intermittent positive airway pressure and assisted spon-
taneous breathing, or by reducing the tidal volume in
pressure-limited intermittent positive pressure ventilation.
A partial carbon dioxide rebreathing technique can be used
to estimate cardiac output in mechanically ventilated patients.
However, carbon dioxide rebreathing can result in increased
minute ventilation and an irregular respiratory pattern.
Tachibana and coworkers [23] reported the use of a shorter
duration of rebreathing (35 s versus 50 s), which mitigated
these effects but yielded a cardiac output measurement that
is similar in accuracy.
Pulmonary artery catheters
Pulmonary capillary pressure (PCP) is the major force
determining fluid filtration from pulmonary capillaries into the
interstitium, and thus it is a major determinant of oedema
formation. Souza and coworkers analyzed pulmonary artery
pressure decay curves in patients with pulmonary hypertension
due to either idiopathic pulmonary arterial hypertension (IPAH;
n = 12) or ARDS (n = 11) [24]. Using a mathematical analysis
based on fitting these curves, they demonstrated that PCP in
IPAH patients is greater than normal, and that the different
algorithms yielded different PCP within the groups. The time
needed to reach steady-state pulmonary arterial occlusion
pressure was longer in the IPAH group (higher time constants).
However, methodological limitations to this occlusion
technique confound interpretation. Different disease processes
may result in different times for arterial emptying, with resulting
implications for the methods available for estimating PCP.
Pulse oxymetry
Respiratory variation in arterial pulse pressure has been
suggested as a predictor of fluid responsiveness in
mechanically ventilated patients with circulatory failure. The
main limitation of this method is that it requires an invasive
arterial  catheter. Cannesson and coworkers [25], in a
prospective clinical trial in 22 mechanically ventilated patients,
demonstrated a strong correlation between respiratory
variation in arterial pulse pressure and respiratory variation in
pulse oximetry plethysmographic waveform amplitude.
Although this was a limited study, a respiratory variation in
pulse oximetry plethysmographic waveform amplitude above
15% accurately discriminated between patients with a
respiratory variation in systemic pulse pressure above 13%
from those with a variation of 13% or less. The study suggests
that this may be a noninvasive approach to assessment of fluid
responsiveness in ventilated patients.
Wang and coworkers [26] reported the novel approach of
using a pulse oximeter to monitor left main bronchus SpO2 by
attaching it to a double lumen tube. SpO2trachea was the same
as SvO2blood in haemodynamically stable animals as well as
during haemorrhagic shock, suggesting that this technique
would be reliable both in the operating theatre and in ICU
patients; as such it may be a possible alternative to the
pulmonary artery catheter for certain measurements.
Education
Training
Abrahamson and coworkers [27] described the effective
implementation of a simulation protocol during SARS to train
health care workers in managing cardiac arrest while wearing
unfamiliar equipment and following a modified advanced
cardiac life support protocol. Simulation provided insights
that had not been considered in earlier phases of develop-
ment of the protocol. It was used to detect and correct flaws
and omissions in a protocol specific to treatment of SARS
patients. The insights gained from this experience will be
valuable for future infectious disease challenges in the ICU.
Health outcomes
Needham and coworkers [28] describe the Improving Care of
ALI Patients (ICAP) study, a multisite, prospective cohort
study that aims to evaluate longer term outcomes of
ALI/ARDS survivors, with a particular focus on the effect of
low tidal volume ventilation and other critical care therapies.
The study is enrolling consecutive mechanically ventilated
ALI/ARDS patients from 11 ICUs at four hospitals in the city
of Baltimore, Maryland, USA, with an expected enrollment of
520 patients over a 2-year period. Exposures (patient based,
clinical management, and ICU organizational) will be
comprehensively collected both at baseline and throughout
the patients’ ICU stays. Outcomes, including mortality, organ
impairment, functional status and quality of life, will be
assessed with the use of standardized surveys and testing at
3, 6, 12 and 24 months after ALI/ARDS diagnosis. A multi-
faceted retention strategy will be used to minimize participant
loss to follow up.
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